ID27759A - Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi - Google Patents

Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi

Info

Publication number: ID27759A
Authority: ID; Indonesia
Prior art keywords: making; benzoilguanidine; derivates; processes; profitable
Prior art date: 1998-09-22

Application number

IDW20010663A

Other languages

English (en)

Inventor

Blech Stefan Matthias

Burger Erich

Eickmeier Christian

Roos Peter

Roos Tamara

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-22

Filing date

1999-09-16

Publication date

2001-04-26

1999-09-16 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2001-04-26 Publication of ID27759A publication Critical patent/ID27759A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Furan Compounds (AREA)
Pyridine Compounds (AREA)

IDW20010663A 1998-09-22 1999-09-16 Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi ID27759A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19843489A DE19843489B4 (de)	1998-09-22	1998-09-22	Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number	Publication Date
ID27759A true ID27759A (id)	2001-04-26

Family

ID=7881872

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010663A ID27759A (id)	1998-09-22	1999-09-16	Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi

Country Status (35)

Country	Link
EP (1)	EP1165534B1 (id)
JP (1)	JP3817425B2 (id)
KR (1)	KR100621821B1 (id)
CN (1)	CN1166654C (id)
AR (1)	AR023668A1 (id)
AT (1)	ATE288425T1 (id)
AU (1)	AU764819C (id)
BG (1)	BG64985B1 (id)
BR (1)	BR9913107A (id)
CA (1)	CA2345006C (id)
CO (1)	CO5150207A1 (id)
CZ (1)	CZ300158B6 (id)
DE (2)	DE19843489B4 (id)
EA (1)	EA004687B1 (id)
EE (1)	EE04749B1 (id)
EG (1)	EG23757A (id)
ES (1)	ES2237951T3 (id)
HK (1)	HK1043367B (id)
HR (1)	HRP20010194B1 (id)
HU (1)	HU228955B1 (id)
ID (1)	ID27759A (id)
IL (1)	IL141805A (id)
MY (1)	MY121362A (id)
NO (1)	NO317993B1 (id)
NZ (1)	NZ511167A (id)
PE (1)	PE20001085A1 (id)
PL (1)	PL195291B1 (id)
PT (1)	PT1165534E (id)
RS (1)	RS49971B (id)
SA (1)	SA99200474B1 (id)
SK (1)	SK285578B6 (id)
TR (1)	TR200100801T2 (id)
TW (1)	TWI221841B (id)
WO (1)	WO2000017176A2 (id)
ZA (1)	ZA200101212B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10106970A1 (de) *	2001-02-15	2002-08-29	Boehringer Ingelheim Pharma	Neues Benzoylguanidinsalz
US6730678B2 (en) *	2001-02-15	2004-05-04	Boehringer Ingelheim Pharma Kg	Benzoylguanidine salt and hydrates thereof
US6982256B2 (en)	2001-09-07	2006-01-03	Boehringer Ingelheim Pharma Kg	Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
DE10144030A1 (de) *	2001-09-07	2003-03-27	Boehringer Ingelheim Pharma	Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin
FR2871157A1 (fr) *	2004-06-04	2005-12-09	Aventis Pharma Sa	Produits biaryl aromatiques, compositions les contenant et utilisation
US20110118262A1 (en) *	2008-07-08	2011-05-19	Boehringer Ingelheim International Gmbh	Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19601303A1 (de) *	1996-01-16	1997-07-17	Boehringer Ingelheim Kg	Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln

1998
- 1998-09-22 DE DE19843489A patent/DE19843489B4/de not_active Expired - Fee Related
1999
- 1999-08-17 SA SA99200474A patent/SA99200474B1/ar unknown
- 1999-09-16 IL IL14180599A patent/IL141805A/xx not_active IP Right Cessation
- 1999-09-16 HR HR20010194A patent/HRP20010194B1/xx not_active IP Right Cessation
- 1999-09-16 ES ES99952453T patent/ES2237951T3/es not_active Expired - Lifetime
- 1999-09-16 TR TR2001/00801T patent/TR200100801T2/xx unknown
- 1999-09-16 HU HU0200225A patent/HU228955B1/hu not_active IP Right Cessation
- 1999-09-16 BR BR9913107-2A patent/BR9913107A/pt not_active IP Right Cessation
- 1999-09-16 PT PT99952453T patent/PT1165534E/pt unknown
- 1999-09-16 RS YUP-215/01A patent/RS49971B/sr unknown
- 1999-09-16 EE EEP200100178A patent/EE04749B1/xx not_active IP Right Cessation
- 1999-09-16 JP JP2000574086A patent/JP3817425B2/ja not_active Expired - Fee Related
- 1999-09-16 CA CA002345006A patent/CA2345006C/en not_active Expired - Fee Related
- 1999-09-16 PL PL99347234A patent/PL195291B1/pl unknown
- 1999-09-16 CZ CZ20011047A patent/CZ300158B6/cs not_active IP Right Cessation
- 1999-09-16 EP EP99952453A patent/EP1165534B1/de not_active Expired - Lifetime
- 1999-09-16 AU AU64659/99A patent/AU764819C/en not_active Ceased
- 1999-09-16 HK HK02105065.7A patent/HK1043367B/zh not_active IP Right Cessation
- 1999-09-16 DE DE59911568T patent/DE59911568D1/de not_active Expired - Lifetime
- 1999-09-16 WO PCT/EP1999/006857 patent/WO2000017176A2/de not_active Ceased
- 1999-09-16 ID IDW20010663A patent/ID27759A/id unknown
- 1999-09-16 SK SK396-2001A patent/SK285578B6/sk not_active IP Right Cessation
- 1999-09-16 EA EA200100317A patent/EA004687B1/ru not_active IP Right Cessation
- 1999-09-16 KR KR1020017003627A patent/KR100621821B1/ko not_active Expired - Fee Related
- 1999-09-16 CN CNB998111430A patent/CN1166654C/zh not_active Expired - Fee Related
- 1999-09-16 AT AT99952453T patent/ATE288425T1/de active
- 1999-09-16 NZ NZ511167A patent/NZ511167A/en not_active IP Right Cessation
- 1999-09-20 PE PE1999000949A patent/PE20001085A1/es not_active Application Discontinuation
- 1999-09-20 MY MYPI99004064A patent/MY121362A/en unknown
- 1999-09-21 CO CO99059852A patent/CO5150207A1/es unknown
- 1999-09-22 AR ARP990104775A patent/AR023668A1/es not_active Application Discontinuation
- 1999-09-22 EG EG118099A patent/EG23757A/xx active
- 1999-09-22 TW TW088116279A patent/TWI221841B/zh not_active IP Right Cessation
2001
- 2001-02-13 ZA ZA200101212A patent/ZA200101212B/en unknown
- 2001-03-09 BG BG105326A patent/BG64985B1/bg unknown
- 2001-03-21 NO NO20011428A patent/NO317993B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ300158B6 (cs)	2009-02-25
CN1342153A (zh)	2002-03-27
YU21501A (sh)	2004-03-12
EG23757A (en)	2007-08-08
EP1165534A2 (de)	2002-01-02
ZA200101212B (en)	2002-10-04
HK1043367A1 (en)	2002-09-13
BG105326A (bg)	2001-11-30
MY121362A (en)	2006-01-28
WO2000017176A3 (de)	2001-10-11
PT1165534E (pt)	2005-04-29
EE200100178A (et)	2002-10-15
HRP20010194A2 (en)	2002-04-30
SK285578B6 (sk)	2007-04-05
HU228955B1 (en)	2013-07-29
WO2000017176A2 (de)	2000-03-30
EE04749B1 (et)	2006-12-15
JP2002538077A (ja)	2002-11-12
NO20011428L (no)	2001-03-21
NZ511167A (en)	2003-12-19
HUP0200225A2 (en)	2002-06-29
IL141805A (en)	2005-12-18
CA2345006A1 (en)	2000-03-30
CO5150207A1 (es)	2002-04-29
KR20010079884A (ko)	2001-08-22
PL195291B1 (pl)	2007-08-31
TR200100801T2 (tr)	2002-04-22
CZ20011047A3 (cs)	2001-08-15
CN1166654C (zh)	2004-09-15
SK3962001A3 (en)	2001-10-08
HUP0200225A3 (en)	2002-12-28
PE20001085A1 (es)	2000-10-25
AR023668A1 (es)	2002-09-04
IL141805A0 (en)	2002-03-10
NO317993B1 (no)	2005-01-17
SA99200474B1 (ar)	2006-06-10
AU764819C (en)	2004-12-16
AU6465999A (en)	2000-04-10
DE19843489A1 (de)	2000-03-23
BR9913107A (pt)	2002-06-11
HRP20010194B1 (en)	2009-05-31
BG64985B1 (bg)	2006-11-30
EP1165534B1 (de)	2005-02-02
EA004687B1 (ru)	2004-06-24
TWI221841B (en)	2004-10-11
AU764819B2 (en)	2003-08-28
EA200100317A1 (ru)	2001-10-22
HK1043367B (zh)	2005-02-25
RS49971B (sr)	2008-09-29
KR100621821B1 (ko)	2006-09-13
ES2237951T3 (es)	2005-08-01
PL347234A1 (en)	2002-03-25
NO20011428D0 (no)	2001-03-21
JP3817425B2 (ja)	2006-09-06
DE19843489B4 (de)	2006-12-21
ATE288425T1 (de)	2005-02-15
DE59911568D1 (de)	2005-03-10
CA2345006C (en)	2007-11-13

Publication	Publication Date	Title
ID25528A (id)	2000-10-12	Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
IL229509A0 (en)	2013-12-31	Preparations containing chemically modified small molecules and processes using them
AU2003271498A8 (en)	2004-05-13	Coolant solutions and compositions comprising the sameitle
IL164021A0 (en)	2005-12-18	Antibodies and anti-pharmaceutical compositions containing the same
TWI340606B (en)	2011-04-11	Polymer compound and polymer luminous element using the same
BR9915457B1 (pt)	2010-09-08	composições de moldagem, uso e artigo.
TWI366071B (en)	2012-06-11	Photosensitive composition, compound for use in the photosensitive composition, and pattern forming method using the photosensitive composition
HUP0500457A3 (en)	2012-09-28	Polyalkylene polymer compounds, compositions containing the same and uses thereof
DE60211163D1 (de)	2006-06-08	Rechnersystem mit dem Modemtreiber in privilegiertem Modus
GB0026054D0 (en)	2000-12-13	Films,compositions and processes
MXPA03004932A (es)	2003-09-10	2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
IL204323A0 (en)	2011-08-01	Compositions useful as multisignal labeling reagents and processes utilizing the same
NO20010873D0 (no)	2001-02-21	Mikropartikkel-blanding
AU2003241742A8 (en)	2003-12-19	Rubber composition and tire obtained from the same
NO20021376D0 (no)	2002-03-20	Sikkerhetsventil nede i brönnen
TWI319762B (en)	2010-01-21	1,7,8-trifluoro-2-naphthol and manufacturing methods for liquid crystal compositions containing the same
SG98483A1 (en)	2003-09-19	Heat-absorbing polymer composition
AU2003218359A1 (en)	2004-04-19	Polymer composition and dosage forms comprising the same
ID28343A (id)	2001-05-17	Kaprolaktam tersubstitusi tertentu, komposisi farmasi yang mengandungnya dan penggunaannya dalam pengobatan tumor
GB2374078B (en)	2005-11-23	Organic anti-reflective coating polymers, anti-reflective coating composition comprising the same and preparation methods thereof
FI20010600L (fi)	2002-09-24	Järjestely luukkurakenteessa
IT1313700B1 (it)	2002-09-09	Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.
GB0000131D0 (en)	2000-02-23	Thiolactomycin analogues,compositions containing the same and uses thereof
GB0207013D0 (en)	2002-05-08	Polymer composition
GB0323138D0 (en)	2003-11-05	Pyrimidines substituted in the 2,4,6 positions and their different uses